Reading Time: 2 minutes
The H. Lundbeck A/S from Denmark specializes in medications for central nervous system disorders. This includes treatments for depression, schizophrenia, Alzheimer’s, Parkinson’s, migraines, and epilepsy. Particularly, the increasing psychological stress, demographic changes, and digitalization are driving the demand for medications. This was also evident in the half-year report published by H. Lundbeck on August 13. According to the report, revenue increased by 14% compared to the same period last year, with particularly high growth in the...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
